![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
北美栓塞剂市场预测至 2028 年 - COVID-19 影响和按产品(线圈、塞子、珠子/颗粒、可拆卸球囊、胶水、海绵、液体栓塞剂、硬化剂、沉淀剂等)、应用(肿瘤学、神经科、泌尿科、心脏病科、周围血管疾病等)和最终用户(医院、心脏中心、门诊手术中心等)
市场介绍
北美栓塞剂市场分为美国、加拿大、和墨西哥。市场的增长广泛归因于全国范围内中风、脑动脉瘤等神经系统疾病发病率的增加。此外,由于政府加大支持来解决对脑部疾病日益增长的担忧,预计加拿大市场的增长将会增长。此外,由于医疗行业的发展以及向美国和其他国家的医疗设备出口的增加,整个墨西哥的市场预计将增长。由于脑动脉瘤病例的增加,预计栓塞剂市场将显着增长。根据脑动脉瘤基金会的报告,美国约有 600 万人患有未破裂的脑动脉瘤。此外,年破裂率接近 8 –每10万人中就有10人,即该国大约有3万人患有脑动脉瘤破裂。此外,从脑动脉瘤破裂中康复的人中,约有七分之四可能患有残疾。这种神经系统疾病通常影响 35 岁以下的人群 - 60 年。不过,脑动脉瘤也可见于儿童,国内女性比男性更容易患脑动脉瘤。尽管脑成像筛查已广泛应用,但诊断延迟往往会导致健康状况恶化。因此,开发先进、微创早期诊断技术的技术进步正在促进该国的新产品创新。这些公司正在推出各种栓塞产品。这些公司积极参与开发,并正在获得 FDA 的各种产品批准。例如,2019 年,MicroVention, Inc. 的 WEB 动脉瘤栓塞系统获得 FDA 的上市前批准。 WEB 系统是同类中第一个用于动脉瘤栓塞的囊内血流干扰器。 2021 年 7 月,Terumo Medical Corporation 最近推出了 AZUR 血管塞,这是第一个也是唯一一个与微导管兼容的塞子,可闭塞直径达 8 毫米的动脉。栓塞组合的这一补充表明可以降低或阻断外周脉管系统动脉中的血流速率。
美国北美地区 COVID-19 病例数最多。疫情对北美国家的医疗行业造成了严重破坏,对抗疾病的诊断和治疗援助需求猛增。此外,COVID-19 大流行给该地区的医疗机构带来了前所未有的运营和临床问题。此外,重点从心血管治疗转向 COVID-19 治疗服务导致 2020 年北美栓塞剂市场增长放缓。患有 CVD 和高血压等合并症的 COVID 患者需要关键的 ICU 资源,并且面临高风险发展进一步的问题。因此,大多数医院和外科中心都考虑取消或推迟择期手术,例如心血管手术。根据胸外科医生协会成人心脏手术数据库和约翰·霍普金斯大学 COVID-19 数据库的数据,美国成人心脏手术量下降了 52.7%,择期手术病例减少了 65.5%。在第一次 COVID-19 激增之后,全国心脏手术病例数下降,表明与 COVID-19 相关的心脏手术患者受到影响。但从长远来看,随着疫苗接种活动的广泛开展和传播率的下降,医疗保健系统正在恢复正常,栓塞产品的需求预计将在未来几年恢复正常。
市场概况和动态
栓塞剂市场北美地区预计将从2021年的10.4125亿美元增长到2028年的17.6373亿美元;预计 2021 年至 2028 年复合年增长率为 7.8%。老年人口基数不断增长;老年人口的增长以及相关神经系统疾病和癌症的增加可能会为市场创造增长机会。疾病、伤害和慢性病在一生中健康风险的积累导致老年人的残疾率更高。根据美国人口普查局的数据,2019 年 7 月,美国 65 岁及以上的居民数量为 5400 万。此外,城市研究所估计,到 2040 年,美国这一年龄段的人口数量将达到 8000 万。因此,不断增长的老年人群可能有利于北美栓塞剂市场的增长。
主要细分市场
根据产品,市场分为线圈、珠子/颗粒、塞子、可拆卸气球、胶水、海绵、液体栓塞剂、硬化剂、沉淀剂等。 2020 年,珠子/颗粒细分市场占据了最大的市场份额。根据线圈,市场分为可拆卸线圈和可推动线圈。可推动的线圈细分市场在 2020 年占据了最大的市场份额。根据珠子/颗粒,市场分为球形和非球形。 2020年,可推动的非球形细分市场占据了最大的市场份额。根据应用,市场分为神经病学、肿瘤学、心脏病学、周围血管疾病等。 2020年,肿瘤学领域可能会占据最大的市场份额。按最终用户划分的栓塞剂市场分为医院、门诊手术中心、心脏中心等。 2020年,医院细分市场占据最大市场份额。
主要来源和上市公司
准备本北美栓塞剂市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库,其中其他的。报告中列出的主要公司有雅培(Abbott);波士顿科学公司;库克医疗有限责任公司;德普合成公司;钟化株式会社;美敦力;梅里特医疗系统公司;半影公司;史赛克公司;以及 Terumo Corporation 等。
购买报告的理由
- 了解北美栓塞剂市场格局并确定最有可能保证丰厚回报的细分市场
- 了解北美栓塞药物市场不断变化的竞争格局,保持领先地位
- 有效规划并购通过识别最有前景的细分市场,在北美栓塞剂市场进行合作和交易
- 通过对各个细分市场表现的敏锐和全面的分析,帮助做出明智的业务决策形成北美栓塞剂市场
- 获取北美地区2021-2028年各细分市场的市场收入预测。
北美栓塞剂市场细分
按产品
- 线圈
- 可拆卸线圈
- 可推动线圈
- 珠子/颗粒
- 球形
- 非球形
- 插头
- 可拆卸气球
- 胶水
- 海绵
- 液体栓塞
- 硬化剂
- 沉淀剂
- 其他
通过申请
- 肿瘤学
- 神经学
- 泌尿学
- < span>心脏病学
- 周围血管疾病
- 其他
作者最终用户
- 医院
- 心脏中心
- 门诊手术中心
- 其他
按国家/地区
- 美国
- 加拿大
- 墨西哥
< span>公司简介
- 雅培
- 波士顿科学公司
- 库克医疗有限责任公司
- DePuy Synthes
- KANEKA CORPORATION
- 美敦力
- Merit Medical Systems Inc
- Penumbra, Inc.
- 史赛克公司
- 泰尔茂公司
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Embolization Agents Market – By Product
1.3.2 North America Embolization Agents Market – By Application
1.3.3 North America Embolization Agents Market – By End User
1.3.4 North America Embolization Agents Market – By Country
2. North America Embolization Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Embolization Agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Experts Opinion
5. North America Embolization Agents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in the Incidence of Tumors and Aneurysms
5.1.2 Growing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 High Cost of Embolization Agents
5.3 Market Opportunities
5.3.1 Growing Geriatric Population Base
5.4 Future Trends
5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact analysis
6. Embolization Agents Market – North America Analysis
6.1 North America Embolization Agents Market Revenue Forecast and Analysis
7. North America Embolization Agents Market Analysis – By Product
7.1 Overview
7.2 North America Embolization Agents Market Revenue Share, by Product (2021 and 2028)
7.3 Coils
7.3.1 Overview
7.3.2 Coils: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Detachable Coils
7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Pushable Coils
7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Beads/Particles
7.4.1 Overview
7.4.2 Beads/Particles: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Spherical
7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2 Non-Spherical
7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Plugs
7.5.1 Overview
7.5.2 Plugs: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Detachable Balloons
7.6.1 Overview
7.6.2 Detachable Balloons: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Glue
7.7.1 Overview
7.7.2 Glue: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Sponge
7.8.1 Overview
7.8.2 Sponge: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Liquid Embolics
7.9.1 Overview
7.9.2 Liquid Embolics: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Sclerosants
7.10.1 Overview
7.10.2 Sclerosants: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11 Precipitating Agents
7.11.1 Overview
7.11.2 Precipitating Agents: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8. North America Embolization Agents Market Analysis – By Application
8.1 Overview
8.2 North America Embolization Agents Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urology
8.5.1 Overview
8.5.2 Urology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Peripheral Vascular Diseases
8.7.1 Overview
8.7.2 Peripheral Vascular Diseases: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Embolization Agents Market Analysis – By End User
9.1 Overview
9.2 North America Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Centers
9.4.1 Overview
9.4.2 Cardiac Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Embolization Agents Market – Country Analysis
10.1 North America: Embolization Agents Market
10.1.1 Overview
10.1.2 North America: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 US Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.2 US Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 Canada Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.2 Canada Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 Mexico Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.2 Mexico Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on North America Embolization Agents Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. North America Embolization Agents Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Terumo Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Stryker Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Penumbra, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merit Medical Systems Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DePuy Synthes
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 KANEKA CORPORATION
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2. US Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. US Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 4. US Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 5. US Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 6. US Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Embolization Agents Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Embolization Agents Market, by Coil - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Embolization Agents Market, by Beads/ Particles - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Embolization Agents Market, By Application - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, North America Embolization Agents Market
LIST OF FIGURES
Figure 1. North America Embolization Agents Market Segmentation
Figure 2. North America Embolization Agents Market Segmentation, By Country
Figure 3. North America Embolization Agents Market Overview
Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in North America Embolization Agents Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8. North America Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. North America Embolization Agents Market Revenue Share, by Product (2021 and 2028)
Figure 10. Coils: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Beads/Particles: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Plugs: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Detachable Balloons: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Glue: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Sponge: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolics: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sclerosants: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Precipitating Agents: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: North America Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21. Oncology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Neurology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Urology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cardiology: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Peripheral Vascular Diseases: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cardiac Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Ambulatory Surgical Centers: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: North America Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. North America: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34. US: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in North American Country Markets
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Penumbra, Inc.
- Stryker Corporation
- Terumo Corporation
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Embolization Agents Market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution